EPISODE · Apr 29, 2026 · 1 MIN
Sunvozertinib Shows Promising First-Line PFS Benefit in EGFR Exon 20 Insertion NSCLC
from TheBrief.Health · host TheBrief.Health
Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over cost, utilization, and sustainability.
What this episode covers
Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over cost, utilization, and sustainability.
NOW PLAYING
Sunvozertinib Shows Promising First-Line PFS Benefit in EGFR Exon 20 Insertion NSCLC
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m